Routine Follow-up Versus Self-assessment in Medical Abortion
- Conditions
- Medical Abortion
- Interventions
- Other: Home self assessment of complete medical abortion
- Registration Number
- NCT01487213
- Lead Sponsor
- Karolinska Institutet
- Brief Summary
The main objective of the study is to optimize the routines for follow-up after medical abortion in order to give women more autonomy by reducing the number of consultations involved and to reduce the frequency of postabortal curettage.
This will be achieved by providing means for women for postabortal self-assessment with the use of a quantitative urinary hCG test.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 929
- women requesting termination of pregnancy by means of mifepristone followed by home administration of misoprostol at < /=63 days of gestation, with no contraindication to medical abortion and self administration of misoprostol at home, and who have given their informed consent will be eligible for study recruitment.
- women who do not wish to participate
- women who do not want home administration of misoprostol
- women who are unable to communicate in Swedish, Norwegian, English, Finnish or German and women with symptoms and signs of ectopic pregnancy
- minors (i.e. women < 18 years of age) will not be enrolled for the study.
- women seeking termination of pregnancy with no sign of a visible intrauterine pregnancy (i.e. visible intrauterine yolk sac).
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Home self test Home self assessment of complete medical abortion Intervention
- Primary Outcome Measures
Name Time Method Number of complete abortions Until 3 months post treatment The primary objective is thus to demonstrate the non-inferiority of self-assessment of complete abortion following medical abortion compared to routine follow-up in terms of the percentage of women requiring surgical abortion, within a margin of non-inferiority of 5%.
- Secondary Outcome Measures
Name Time Method adverse events util 3 months post treatment Number of women reporting adverse events and side effects including infections, bleeding, pain
postabortion contraception until 12 months post treatment The use of contraception and rate of repeat abortion at follow-up questionnaire at one year.
Trial Locations
- Locations (4)
Dept. Obstetrics and Gynaecology,Helsinki University Central Hospital
🇫🇮Helsinki, Finland
GynMed Clinic
🇦🇹Vienna, Austria
Faculty of Medicine, University of Oslo and Dept. of Gynaecology,
🇳🇴Oslo, Norway
Dept of Obstetrics and Gynecology, Karolinska University Hospital
🇸🇪Stockholm, Sweden